BMCC-2022-STU06-2

Tumor-Infiltrating Lymphocytes (TILs) Isolation with Microfluidic-Capture Microdissection (MCM) System

BMCC

The SACA system, which utilizes a variety of technology including a dynamic Live- cell Staining Microdialysis Chip and Patient-Derive Explants Platform used for profiling, allows for more efficient response assessment and selection for cancer immunotherapy. We developed a Microfluidic-capture Microdissection (MCM) system for single cell isolation based on nondestructive sampling, providing highly customized & quality total solutions to procure subpopulations of live tissue cells or PMBC in blood.

未定中標題
BMCC Targeted indication

Cancer Immune-cell Therapy

BMCC Status

Prototype platform of Microfluidic-capture Microdissection (MCM) for validation of the possibility of therapeutic tumor- infiltrating lymphocytes (TILs) isolation can cultured

BMCC Key features
  • Without of flow cytometry & magnetic beads selection
  • Therapeutic tumor-infiltrating lymphocytes (TILs) be isolated from tumor tissue or circulating tumor microemboli(CTM)
  • Identification of neoantigen-specific T cells in PBMC
BMCC Market

MODE OF ACTION